These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. Becker GL; Lu Y; Hardes K; Strehlow B; Levesque C; Lindberg I; Sandvig K; Bakowsky U; Day R; Garten W; Steinmetzer T J Biol Chem; 2012 Jun; 287(26):21992-2003. PubMed ID: 22539349 [TBL] [Abstract][Full Text] [Related]
7. Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes. Basak A; Lazure C Biochem J; 2003 Jul; 373(Pt 1):231-9. PubMed ID: 12662153 [TBL] [Abstract][Full Text] [Related]
13. Cyclic amidine sugars as transition-state analogue inhibitors of glycosidases: potent competitive inhibitors of mannosidases. Heck MP; Vincent SP; Murray BW; Bellamy F; Wong CH; Mioskowski C J Am Chem Soc; 2004 Feb; 126(7):1971-9. PubMed ID: 14971930 [TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel series of potent and selective substrate-based inhibitors of p60c-src protein tyrosine kinase: conformational and topographical constraints in peptide design. Alfaro-Lopez J; Yuan W; Phan BC; Kamath J; Lou Q; Lam KS; Hruby VJ J Med Chem; 1998 Jun; 41(13):2252-60. PubMed ID: 9632358 [TBL] [Abstract][Full Text] [Related]
15. Chemical structure and properties of low-molecular furin inhibitors. Osadchuk TV; Shybyryn OV; Kibirev VK Ukr Biochem J; 2016; 88(6):5-25. PubMed ID: 29235831 [TBL] [Abstract][Full Text] [Related]
16. Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect. Biela A; Sielaff F; Terwesten F; Heine A; Steinmetzer T; Klebe G J Med Chem; 2012 Jul; 55(13):6094-110. PubMed ID: 22612268 [TBL] [Abstract][Full Text] [Related]
17. Cell-permeable and plasma-stable peptidomimetic inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction. Bach A; Eildal JN; Stuhr-Hansen N; Deeskamp R; Gottschalk M; Pedersen SW; Kristensen AS; Strømgaard K J Med Chem; 2011 Mar; 54(5):1333-46. PubMed ID: 21322614 [TBL] [Abstract][Full Text] [Related]
18. Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products. Ingallinella P; Altamura S; Bianchi E; Taliani M; Ingenito R; Cortese R; De Francesco R; Steinkühler C; Pessi A Biochemistry; 1998 Jun; 37(25):8906-14. PubMed ID: 9636032 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R₈ERY. Papst S; Noisier AF; Brimble MA; Yang Y; Krissansen GW Bioorg Med Chem; 2012 Sep; 20(17):5139-49. PubMed ID: 22877871 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship study of a CXC chemokine receptor type 4 antagonist, FC131, using a series of alkene dipeptide isosteres. Kobayashi K; Oishi S; Hayashi R; Tomita K; Kubo T; Tanahara N; Ohno H; Yoshikawa Y; Furuya T; Hoshino M; Fujii N J Med Chem; 2012 Mar; 55(6):2746-57. PubMed ID: 22352868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]